nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—Connective tissue disorder—Desloratadine—allergic rhinitis	0.0157	0.0197	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—FOXP3—allergic rhinitis	0.0134	0.0654	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Desloratadine—allergic rhinitis	0.0127	0.016	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-G—allergic rhinitis	0.0122	0.0594	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL13—allergic rhinitis	0.0115	0.0559	CbGpPWpGaD
Azilsartan medoxomil—Muscle spasms—Olopatadine—allergic rhinitis	0.0114	0.0144	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Desloratadine—allergic rhinitis	0.0111	0.014	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL17A—allergic rhinitis	0.0106	0.0515	CbGpPWpGaD
Azilsartan medoxomil—Fatigue—Cyproheptadine—allergic rhinitis	0.01	0.0126	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Olopatadine—allergic rhinitis	0.01	0.0126	CcSEcCtD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—TGFB1—allergic rhinitis	0.01	0.0487	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL5—allergic rhinitis	0.00984	0.0479	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.00977	0.0123	CcSEcCtD
Azilsartan medoxomil—Fatigue—Desloratadine—allergic rhinitis	0.00976	0.0123	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Cetirizine—allergic rhinitis	0.00952	0.012	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Olopatadine—allergic rhinitis	0.00949	0.0119	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Olopatadine—allergic rhinitis	0.0094	0.0118	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Flunisolide—allergic rhinitis	0.00936	0.0118	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.00836	0.0105	CcSEcCtD
Azilsartan medoxomil—Asthenia—Cyproheptadine—allergic rhinitis	0.00836	0.0105	CcSEcCtD
Azilsartan medoxomil—Fatigue—Olopatadine—allergic rhinitis	0.00835	0.0105	CcSEcCtD
Azilsartan medoxomil—Angioedema—Loratadine—allergic rhinitis	0.00817	0.0103	CcSEcCtD
Azilsartan medoxomil—Fatigue—Diphenhydramine—allergic rhinitis	0.00817	0.0103	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dimenhydrinate—allergic rhinitis	0.00817	0.0103	CcSEcCtD
Azilsartan medoxomil—Asthenia—Desloratadine—allergic rhinitis	0.00812	0.0102	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Cetirizine—allergic rhinitis	0.00809	0.0102	CcSEcCtD
Azilsartan medoxomil—Pruritus—Desloratadine—allergic rhinitis	0.00801	0.0101	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Cyproheptadine—allergic rhinitis	0.00797	0.01	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Montelukast—allergic rhinitis	0.00796	0.01	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Desloratadine—allergic rhinitis	0.00775	0.00975	CcSEcCtD
Azilsartan medoxomil—Dizziness—Cyproheptadine—allergic rhinitis	0.0077	0.0097	CcSEcCtD
Azilsartan medoxomil—Angioedema—Cetirizine—allergic rhinitis	0.00769	0.00967	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.00762	0.0371	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.00757	0.0368	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.00756	0.00951	CcSEcCtD
Azilsartan medoxomil—Dizziness—Desloratadine—allergic rhinitis	0.00749	0.00942	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00746	0.0363	CbGpPWpGaD
Azilsartan medoxomil—Rash—Cyproheptadine—allergic rhinitis	0.00734	0.00924	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Cyproheptadine—allergic rhinitis	0.00734	0.00924	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.00722	0.0351	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL10—allergic rhinitis	0.00719	0.035	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Loratadine—allergic rhinitis	0.00715	0.00901	CcSEcCtD
Azilsartan medoxomil—Rash—Desloratadine—allergic rhinitis	0.00714	0.00899	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Desloratadine—allergic rhinitis	0.00713	0.00898	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.00711	0.00895	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Loratadine—allergic rhinitis	0.00709	0.00892	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL4—allergic rhinitis	0.007	0.034	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Olopatadine—allergic rhinitis	0.00695	0.00874	CcSEcCtD
Azilsartan medoxomil—Nausea—Cyproheptadine—allergic rhinitis	0.00692	0.00871	CcSEcCtD
Azilsartan medoxomil—Pruritus—Olopatadine—allergic rhinitis	0.00685	0.00862	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dimenhydrinate—allergic rhinitis	0.0068	0.00856	CcSEcCtD
Azilsartan medoxomil—Asthenia—Diphenhydramine—allergic rhinitis	0.0068	0.00856	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Montelukast—allergic rhinitis	0.00678	0.00854	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00677	0.0329	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Cetirizine—allergic rhinitis	0.00673	0.00847	CcSEcCtD
Azilsartan medoxomil—Nausea—Desloratadine—allergic rhinitis	0.00673	0.00847	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Cetirizine—allergic rhinitis	0.00667	0.00839	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Olopatadine—allergic rhinitis	0.00662	0.00834	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Diphenhydramine—allergic rhinitis	0.00648	0.00816	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.00648	0.00816	CcSEcCtD
Azilsartan medoxomil—Angioedema—Montelukast—allergic rhinitis	0.00645	0.00811	CcSEcCtD
Azilsartan medoxomil—Dizziness—Olopatadine—allergic rhinitis	0.0064	0.00806	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00639	0.0311	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.0063	0.00793	CcSEcCtD
Azilsartan medoxomil—Fatigue—Loratadine—allergic rhinitis	0.00629	0.00792	CcSEcCtD
Azilsartan medoxomil—Dizziness—Diphenhydramine—allergic rhinitis	0.00626	0.00789	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dimenhydrinate—allergic rhinitis	0.00626	0.00789	CcSEcCtD
Azilsartan medoxomil—Rash—Olopatadine—allergic rhinitis	0.0061	0.00768	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Olopatadine—allergic rhinitis	0.0061	0.00768	CcSEcCtD
Azilsartan medoxomil—Rash—Dimenhydrinate—allergic rhinitis	0.00597	0.00752	CcSEcCtD
Azilsartan medoxomil—Rash—Diphenhydramine—allergic rhinitis	0.00597	0.00752	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Diphenhydramine—allergic rhinitis	0.00597	0.00751	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dimenhydrinate—allergic rhinitis	0.00597	0.00751	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.00596	0.00751	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.00593	0.00746	CcSEcCtD
Azilsartan medoxomil—Fatigue—Cetirizine—allergic rhinitis	0.00592	0.00745	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00585	0.0285	CbGpPWpGaD
Azilsartan medoxomil—Fatigue—Flunisolide—allergic rhinitis	0.00582	0.00733	CcSEcCtD
Azilsartan medoxomil—Nausea—Olopatadine—allergic rhinitis	0.00575	0.00724	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Montelukast—allergic rhinitis	0.00565	0.00711	CcSEcCtD
Azilsartan medoxomil—Nausea—Dimenhydrinate—allergic rhinitis	0.00563	0.00708	CcSEcCtD
Azilsartan medoxomil—Nausea—Diphenhydramine—allergic rhinitis	0.00563	0.00708	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Montelukast—allergic rhinitis	0.00559	0.00704	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00531	0.0258	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.00524	0.0255	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Loratadine—allergic rhinitis	0.00523	0.00659	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	0.00508	0.0247	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.00501	0.0244	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Loratadine—allergic rhinitis	0.00499	0.00628	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.00497	0.00626	CcSEcCtD
Azilsartan medoxomil—Fatigue—Montelukast—allergic rhinitis	0.00496	0.00625	CcSEcCtD
Azilsartan medoxomil—Asthenia—Cetirizine—allergic rhinitis	0.00493	0.0062	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00486	0.0237	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Cetirizine—allergic rhinitis	0.00486	0.00611	CcSEcCtD
Azilsartan medoxomil—Asthenia—Flunisolide—allergic rhinitis	0.00484	0.0061	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.00484	0.0235	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Loratadine—allergic rhinitis	0.00482	0.00607	CcSEcCtD
Azilsartan medoxomil—Pruritus—Flunisolide—allergic rhinitis	0.00478	0.00601	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00475	0.0231	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Cetirizine—allergic rhinitis	0.0047	0.00591	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Flunisolide—allergic rhinitis	0.00462	0.00581	CcSEcCtD
Azilsartan medoxomil—Rash—Loratadine—allergic rhinitis	0.0046	0.00579	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Loratadine—allergic rhinitis	0.0046	0.00579	CcSEcCtD
Azilsartan medoxomil—Dizziness—Cetirizine—allergic rhinitis	0.00454	0.00571	CcSEcCtD
Azilsartan medoxomil—Dizziness—Flunisolide—allergic rhinitis	0.00446	0.00562	CcSEcCtD
Azilsartan medoxomil—Nausea—Loratadine—allergic rhinitis	0.00433	0.00546	CcSEcCtD
Azilsartan medoxomil—Rash—Cetirizine—allergic rhinitis	0.00433	0.00545	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Cetirizine—allergic rhinitis	0.00432	0.00544	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.0043	0.00541	CcSEcCtD
Azilsartan medoxomil—Rash—Flunisolide—allergic rhinitis	0.00426	0.00536	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Flunisolide—allergic rhinitis	0.00425	0.00535	CcSEcCtD
Azilsartan medoxomil—Asthenia—Montelukast—allergic rhinitis	0.00413	0.0052	CcSEcCtD
Azilsartan medoxomil—Nausea—Cetirizine—allergic rhinitis	0.00408	0.00513	CcSEcCtD
Azilsartan medoxomil—Pruritus—Montelukast—allergic rhinitis	0.00407	0.00513	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.00404	0.00509	CcSEcCtD
Azilsartan medoxomil—Nausea—Flunisolide—allergic rhinitis	0.00401	0.00505	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Montelukast—allergic rhinitis	0.00394	0.00496	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00382	0.0186	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Montelukast—allergic rhinitis	0.00381	0.00479	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Methylprednisolone—allergic rhinitis	0.00373	0.00469	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL11—allergic rhinitis	0.00369	0.0179	CbGpPWpGaD
Azilsartan medoxomil—Rash—Montelukast—allergic rhinitis	0.00363	0.00457	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Montelukast—allergic rhinitis	0.00363	0.00456	CcSEcCtD
Azilsartan medoxomil—Angioedema—Prednisolone—allergic rhinitis	0.00356	0.00449	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00352	0.0171	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Hydrocortisone—allergic rhinitis	0.00348	0.00438	CcSEcCtD
Azilsartan medoxomil—Nausea—Montelukast—allergic rhinitis	0.00342	0.0043	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Betamethasone—allergic rhinitis	0.00339	0.00427	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Dexamethasone—allergic rhinitis	0.00339	0.00427	CcSEcCtD
Azilsartan medoxomil—Angioedema—Triamcinolone—allergic rhinitis	0.00328	0.00413	CcSEcCtD
Azilsartan medoxomil—Angioedema—Methylprednisolone—allergic rhinitis	0.00327	0.00412	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.00322	0.00405	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.00305	0.00384	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.00303	0.00381	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Hydrocortisone—allergic rhinitis	0.00302	0.0038	CcSEcCtD
Azilsartan medoxomil—Angioedema—Betamethasone—allergic rhinitis	0.00297	0.00374	CcSEcCtD
Azilsartan medoxomil—Angioedema—Dexamethasone—allergic rhinitis	0.00297	0.00374	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TGFB1—allergic rhinitis	0.00293	0.0143	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.00286	0.00361	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Methylprednisolone—allergic rhinitis	0.00284	0.00357	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00275	0.0134	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.00268	0.00338	CcSEcCtD
Azilsartan medoxomil—Fatigue—Hydrocortisone—allergic rhinitis	0.00268	0.00337	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TAC1—allergic rhinitis	0.00268	0.013	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Dexamethasone—allergic rhinitis	0.0026	0.00328	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Betamethasone—allergic rhinitis	0.0026	0.00328	CcSEcCtD
Azilsartan medoxomil—Fatigue—Triamcinolone—allergic rhinitis	0.00252	0.00318	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methylprednisolone—allergic rhinitis	0.00252	0.00317	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.0025	0.0121	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.00229	0.00289	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.00229	0.00289	CcSEcCtD
Azilsartan medoxomil—Fatigue—Betamethasone—allergic rhinitis	0.00229	0.00288	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dexamethasone—allergic rhinitis	0.00229	0.00288	CcSEcCtD
Azilsartan medoxomil—Asthenia—Hydrocortisone—allergic rhinitis	0.00223	0.00281	CcSEcCtD
Azilsartan medoxomil—Pruritus—Hydrocortisone—allergic rhinitis	0.0022	0.00277	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.00216	0.0105	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Hydrocortisone—allergic rhinitis	0.00213	0.00268	CcSEcCtD
Azilsartan medoxomil—Dizziness—Prednisolone—allergic rhinitis	0.0021	0.00265	CcSEcCtD
Azilsartan medoxomil—Asthenia—Triamcinolone—allergic rhinitis	0.0021	0.00264	CcSEcCtD
Azilsartan medoxomil—Asthenia—Methylprednisolone—allergic rhinitis	0.0021	0.00264	CcSEcCtD
Azilsartan medoxomil—Pruritus—Triamcinolone—allergic rhinitis	0.00207	0.00261	CcSEcCtD
Azilsartan medoxomil—Pruritus—Methylprednisolone—allergic rhinitis	0.00207	0.0026	CcSEcCtD
Azilsartan medoxomil—Dizziness—Hydrocortisone—allergic rhinitis	0.00206	0.00259	CcSEcCtD
Azilsartan medoxomil—Rash—Prednisolone—allergic rhinitis	0.00201	0.00253	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisolone—allergic rhinitis	0.00201	0.00252	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methylprednisolone—allergic rhinitis	0.002	0.00252	CcSEcCtD
Azilsartan medoxomil—Rash—Hydrocortisone—allergic rhinitis	0.00196	0.00247	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00196	0.00953	CbGpPWpGaD
Azilsartan medoxomil—Dermatitis—Hydrocortisone—allergic rhinitis	0.00196	0.00247	CcSEcCtD
Azilsartan medoxomil—Dizziness—Triamcinolone—allergic rhinitis	0.00194	0.00244	CcSEcCtD
Azilsartan medoxomil—Dizziness—Methylprednisolone—allergic rhinitis	0.00193	0.00243	CcSEcCtD
Azilsartan medoxomil—Asthenia—Betamethasone—allergic rhinitis	0.00191	0.0024	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dexamethasone—allergic rhinitis	0.00191	0.0024	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL11—allergic rhinitis	0.00189	0.0092	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Prednisolone—allergic rhinitis	0.00189	0.00238	CcSEcCtD
Azilsartan medoxomil—Pruritus—Dexamethasone—allergic rhinitis	0.00188	0.00237	CcSEcCtD
Azilsartan medoxomil—Pruritus—Betamethasone—allergic rhinitis	0.00188	0.00237	CcSEcCtD
Azilsartan medoxomil—Nausea—Hydrocortisone—allergic rhinitis	0.00185	0.00232	CcSEcCtD
Azilsartan medoxomil—Rash—Triamcinolone—allergic rhinitis	0.00185	0.00232	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Triamcinolone—allergic rhinitis	0.00184	0.00232	CcSEcCtD
Azilsartan medoxomil—Rash—Methylprednisolone—allergic rhinitis	0.00184	0.00232	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Methylprednisolone—allergic rhinitis	0.00184	0.00232	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dexamethasone—allergic rhinitis	0.00182	0.00229	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Betamethasone—allergic rhinitis	0.00182	0.00229	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dexamethasone—allergic rhinitis	0.00176	0.00221	CcSEcCtD
Azilsartan medoxomil—Dizziness—Betamethasone—allergic rhinitis	0.00176	0.00221	CcSEcCtD
Azilsartan medoxomil—Nausea—Triamcinolone—allergic rhinitis	0.00174	0.00219	CcSEcCtD
Azilsartan medoxomil—Nausea—Methylprednisolone—allergic rhinitis	0.00173	0.00218	CcSEcCtD
Azilsartan medoxomil—Rash—Dexamethasone—allergic rhinitis	0.00167	0.00211	CcSEcCtD
Azilsartan medoxomil—Rash—Betamethasone—allergic rhinitis	0.00167	0.00211	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Betamethasone—allergic rhinitis	0.00167	0.00211	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dexamethasone—allergic rhinitis	0.00167	0.00211	CcSEcCtD
Azilsartan medoxomil—Nausea—Dexamethasone—allergic rhinitis	0.00158	0.00199	CcSEcCtD
Azilsartan medoxomil—Nausea—Betamethasone—allergic rhinitis	0.00158	0.00199	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TAC1—allergic rhinitis	0.00151	0.00736	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTGDR2—allergic rhinitis	0.00147	0.00717	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL5—allergic rhinitis	0.00141	0.00685	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TAC1—allergic rhinitis	0.00137	0.00669	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL5—allergic rhinitis	0.00128	0.00622	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00116	0.00563	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL11—allergic rhinitis	0.00112	0.00544	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TAC1—allergic rhinitis	0.000812	0.00395	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL5—allergic rhinitis	0.000755	0.00367	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SMAD3—allergic rhinitis	0.000531	0.00258	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NFKB1—allergic rhinitis	0.00027	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—allergic rhinitis	0.000225	0.00109	CbGpPWpGaD
